Impact of social isolation on mortality and morbidity in 20 high-income, middle-income and low-income countries in five continents
| Primer Autor |
Yusuf, Salim
|
| Título |
Impact of social isolation on mortality and morbidity in 20 high-income, middle-income and low-income countries in five continents
|
| Editorial |
BMJ PUBLISHING GROUP
|
| Revista |
BMJ GLOBAL HEALTH
|
| Lenguaje |
en
|
| Tipo de Recurso |
artículo original
|
| Derecho de Acceso |
acceso abierto
|
| Description |
SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario.The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies [with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline], and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: This study was supported by an unrestricted grant from Dairy Far mers of Canada and the National Dairy Council (U.S.), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera [DI13-PE11], China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr.Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (Research group number: RG -1436-013), Riyadh, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia, South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.
|
| doi |
10.1136/bmjgh-2020-004124
|
| Formato Recurso |
pdf
|
| Palabras Claves |
public health
|
| Ubicación del archivo | |
| Categoría OCDE |
Salud pública, ambiental y ocupacional
|
| Materias |
salud publica
|
| Disciplinas de la OCDE |
Salud Pública y Ambiental
|
| Id de Web of Science |
WOS:000632920200004
|
| Access Rights |
acceso abierto
|
| Derechos de acceso |
acceso abierto
|
| Título de la cita (Recomendado-único) |
Impact of social isolation on mortality and morbidity in 20 high-income, middle-income and low-income countries in five continents
|
| Identificador del recurso (Mandatado-único) |
artículo original
|
| Versión del recurso (Recomendado-único) |
version publicada
|
| Editorial |
BMJ PUBLISHING GROUP
|
| Revista/Libro |
BMJ GLOBAL HEALTH
|
| Categoría WOS |
Salud pública, ambiental y ocupacional
|
| Idioma |
en
|
| ISSN |
2059-7908
|
| Descripción |
SY is supported by the Marion W Burke endowed chair of the Heart and Stroke Foundation of Ontario.The PURE study is an investigator-initiated study that is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute (HHSRI), the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Support from Canadian Institutes of Health Research's Strategy for Patient Oriented Research, through the Ontario SPOR Support Unit, as well as the Ontario Ministry of Health and Long-Term Care and through unrestricted grants from several pharmaceutical companies [with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), Servier, and GlaxoSmithKline], and additional contributions from Novartis and King Pharma and from various national or local organisations in participating countries. These include: Argentina: Fundacion ECLA (Estudios Clinicos Latino America), Bangladesh: Independent University, Bangladesh and Mitra and Associates, Brazil: Unilever Health Institute, Brazil, Canada: This study was supported by an unrestricted grant from Dairy Far mers of Canada and the National Dairy Council (U.S.), Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network, Chile: Universidad de La Frontera [DI13-PE11], China: National Center for Cardiovascular Diseases and ThinkTank Research Center for Health Development, Colombia: Colciencias (grant 6566-04-18062 and grant 6517-777-58228), India: Indian Council of Medical Research, Malaysia: Ministry of Science, Technology and Innovation of Malaysia (grant number: 100-IRDC/BIOTEK 16/6/21 [13/2007], and 07-05-IFN-BPH 010), Ministry of Higher Education of Malaysia (grant number: 600-RMI/LRGS/5/3 [2/2011]), Universiti Teknologi MARA, Universiti Kebangsaan Malaysia (UKM-Hejim-Komuniti-15-2010), occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory, International Development Research Centre, Canada, Philippines: Philippine Council for Health Research and Development, Poland: Polish Ministry of Science and Higher Education (grant number: 290/W-PURE/2008/0), Wroclaw Medical University, Saudi Arabia: Saudi Heart Association, Dr.Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University (Research group number: RG -1436-013), Riyadh, Saleh Hamza Serafi Chair for Research of Coronary Heart Disease, Umm AlQura University, Makkah, Saudi Arabia, South Africa: The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences, Sweden: Grants from the Swedish state under the Agreement concerning research and education of doctors, the Swedish Heart and Lung Foundation, the Swedish Research Council, the Swedish Council for Health, Working Life and Welfare, King Gustaf V:s and Queen Victoria Freemason's Foundation, AFA Insurance, Turkey: Metabolic Syndrome Society, AstraZeneca, Sanofi Aventis, United Arab Emirates: Sheikh Hamdan Bin Rashid Al Maktoum Award For Medical Sciences and Dubai Health Authority, Dubai.
|
| Referencia del Financiador (Mandatado si es aplicable-repetible) |
Heart and Stroke
HHSRI
UFRO DI13-PE11
PHRI
CIRH
Canadian Institutes of Health Research
Ontario Ministry of Health and Long-Term Care
AstraZeneca (Canada)
Sanofi-Aventis (France and Canada)
Boehringer Ingelheim (Germany and Canada)
Servier
GlaxoSmithKline
Novartis and King Pharma
Fundacion ECLA
Independent University, Bangladesh and Mitra and Associates
Unilever Health Institute
Canada and the National Dairy Council (U.S.)
Public Health Agency of Canada and Champlain Cardiovascular Disease Prevention Network
National Center for Cardiovascular Diseases
ThinkTank Research Center for Health Development
ColCiencias 6566-04-18062
ColCiencias 6517-777-58228
Indian Council of Medical Research
MOSTI 100-IRDC/BIOTEK 16/6/21 13/2007
MOSTI 07-05-IFN-BPH 010
MOHE 600-RMI/LRGS/5/3 [2/2011]
Universiti Teknologi MARA
Universiti Kebangsaan Malaysia UKM-Hejim-Komuniti-15-2010
occupied Palestinian territory: the United Nations Relief and Works Agency for Palestine Refugees in the Near East, occupied Palestinian territory
International Development Research Centre
Philippine Council for Health Research and Development
Polish Ministry of Science and Higher Education 290/W-PURE/2008/0
Wroclaw Medical University
Saudi Heart Association, Dr.Mohammad Alfagih Hospital, The Deanship of Scientific Research at King Saud University RG -1436-013
Saleh Hamza Serafi Chair for Research of Coronary Heart Disease
Umm AlQura University, Makkah, Saudi Arabia
The North-West University, SA and Netherlands Programme for Alternative Development, National Research Foundation, Medical Research Council of South Africa, The South Africa Sugar Association, Faculty of Community and Health Sciences
Swedish Heart and Lung Foundation
Swedish Research Council
Swedish Council for Health, Working Life and Welfare, King Gustaf V and Queen Victoria Freemason's Foundation
AFA Insurance
Metabolic Syndrome Society
AstraZeneca
Sanofi Aventis
Sheikh Hamdan Bin Rashid Al Maktoum
|
| Tipo de ruta |
dorada
verde
|
| Formato |
pdf
|
- Colecciones
- Colección Publicaciones Científicas
cienciaabierta.ufro.cl
ciencia.abierta@ufrontera.cl